Hormone replacement therapy

Deep vein thrombosis - Hormone replacement therapy Factor

Last reviewed for CCPS 22 December 2008.

Preliminary questions [21467]

21468 there is some evidence that hormone replacement therapy may be a factor in the development of the condition under consideration.

9172 the veteran has had a course of hormone replacement therapy at some time.

23828 the veteran has had hormone replacement therapy for treatment of an illness or injury which is identifiable.

21469

the veteran had hormone replacement therapy for treatment of the identified illness or injury for a period of at least three weeks within the 90 days before the clinical onset of the condition under consideration.

21470 — the veteran has established the causal connection between the hormone replacement therapy and VEA service for the clinical onset of deep vein thrombosis.

21471 — the veteran has established the causal connection between the hormone replacement therapy and operational service for the clinical onset of deep vein thrombosis.

or

21472 — the veteran has established the causal connection between the hormone replacement therapy and eligible service for the clinical onset of deep vein thrombosis.

Clinical onset and operational service [21471]

8823 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service.

Clinical onset and eligible service [21472]

8824 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service.